Fargo, United States
Aldevron, founded in 1998, operates in the fields of Biotechnology, Industrial, and Manufacturing, with its headquarters located in the United States. The company aims to foster a world where "every cure is possible." This mission aligns with its focus on leveraging advanced scientific and technological solutions to enhance global healthcare improvements.
As a part of Danaher, Aldevron benefits from the corporation's broad expertise and expansive resources. The collaboration with Danaher's other businesses in Biotechnology, Diagnostics, and Life Sciences places Aldevron in a strategic position to exploit cutting-edge technologies for transformative health impacts worldwide.
In a significant move, Danaher invested $9.60B to acquire Aldevron on 01 June 2021. This acquisition underscores Danaher's commitment to enhancing its industry leadership and signals potential growth and innovation opportunities for Aldevron through enhanced synergies and resource optimization.
